Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers in Spinocerebellar Ataxias

24 May 2025

Abstract excerpt

Biomarkers are defined as measures that indicate biological processes and responses to interventions. Spinocerebellar ataxias (SCAs) are autosomal dominantly inherited, progressive diseases. As targeted therapies for SCAs are being developed, there is a great need for biomarkers for use in clinical trials. Molecular genetic tests are firmly established as diagnostic biomarkers for SCAs. Biomarkers that monitor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40411538
DOI: 10.1007/s12311-025-01856-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers in Spinocerebellar AtaxiasPMID 40411538Read ↗

Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of viewSemantic proximity Read ↗

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortSemantic proximity Read ↗

Neurophysiological features in spinocerebellar ataxia type 2: Prospects for novel biomarkersSemantic proximity Read ↗

Biomarkers in Motor Neuron Disease: A State of the Art ReviewSemantic proximity Read ↗

Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxiaSemantic proximity Read ↗

Stage-dependent biomarker changes in spinocerebellar ataxia type 3Semantic proximity Read ↗

The Current State of Biomarker Research for Friedreich’s Ataxia: A Report From the 2018 FARA Biomarker MeetingSemantic proximity Read ↗

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.Semantic proximity Read ↗

Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Semantic proximity Read ↗

Association of serum neurofilament light and disease severity in patients with spinocerebellar ataxia type 3.Semantic proximity Read ↗

Biomarkers in 5q-associated spinal muscular atrophy-a narrative review.Semantic proximity Read ↗

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.